Résumé
Bien que, comparés aux carcinomes, les lymphomes du tractus digestif soient extrêment rares, leur incidence est croissante. Cette croissance peut s'expliquer par une augmentation de l'incidence des perturbation liées à l'immunodéficience, elles-mêmes associées à une augmentation du risque de développer des lymphomes gastro-intestinaux. Les lymphomes gastro-intestinaux sont principalement des lymphomes B de type diffus à grandes cellules et des lymphomes de la zone marginale. Malgré la rareté des autres types de lymphomes tels les lymphomes du manteau, les lymphomes folliculaires ou les lymphomes T associés a une entéropathie, la classification REAL tout comme la classification publiée récemment par l'OMS, considèrent ces lymphomes comme des entités distinctes en se basant sur leur morphologie, l'immunohistochimie, la cytogénétique et leur présentation clinique.
Summary
Although, in comparison to gastro-intestinal carcinomas, lymphomas of the gastro-intestinal tract are extremely rare, the incidence of these tumours is rising. This rise may be explained by the increasing incidence of immunodeficiency disorders, as these disorders are associated with an increased risk for development of gastro-intestinal lymphomas. Gastro-intestinal lymphomas are mainly diffuse large B-cell lymphomas and marginal zone cell lymphomas. Despite other types of lymphomas such as e.g. mantle cell lymphomas, follicular lymphomas or enteropathy-type T-cell lymphomas are uncommon, the REAL-classification as well as the recently published World Health Organization classification of lymphoid neoplasms consider these tumours as distinct entities, based on their morphology, immunohistochemistry, cytogenetics as well as on their different clinical presentation.
Article PDF
Avoid common mistakes on your manuscript.
Références
ABBONDANZO S.L., SOBIN L.H. — Gastric «pseudolymphoma». A retrospective morphologic and immunophenotypic study of 97 cases.Cancer, 1997,79, 1656–1663.
DEVESA S.S., FEARS T. — Non-Hodgkin's lymphoma time trends: United States and international data.Cancer Res., 1992,52 (suppl.), 5432s-5440s.
THOMAS J.A., ALLADAY M.J., CRAWFORD D.H. — Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals.Adv. Cancer Res., 1991,57, 329–380.
AZAB M.B., HENRY-AMAR M., ROUGIER P., BOGNEL C., THEODORE C., CARDE P., LASSER P., COSSET J., CAILLOU B., DROZ J., HAYAT M. — Prognostic factors in primary gastrointestinal Non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.Cancer, 1989,4, 1208–1217.
CRUMP M., GOSPODAROWICZ M., SHEPHERD F.A. — Lymphoma of the gastrointestinal tract.Semin. Oncol., 1999,26, 324–337.
HAMILTON S.R., AALTONEN L.A. — World Health Organization Classification of tumours. Pathology and genetics of tumours of the digestive system. IARC Press: Lyon, 2000.
ISAACSON P.G., SPENCER G., WRIGHT D.H. — Classifying primary gut lymphomas.Lancet, 1988,2, 1148–1149.
HARRIS N.L., JAFFE E.S., STEIN H., BANKS P., CHAN J.K.C., CLEARY M.L., DELSOL G., DE WOLF-PEETERS C., FALINI B., GATTER K.C., GROGAN T.M., ISAACSON P.G., KNOWLES D.M., MASON D.Y., MÜLLER-HERMELINK H.K., PILERI S.A., PIRIS M.A., RALFKIAER E., WARNKE R.A. — A Revised European-American Classification of Lymphoid Neoplasms: A Proposal From The International Lymphoma Study Group.Blood, 1994,84, 1361–1392.
HARRIS N.L., JAFFE E.S., DIEBOLD J., FLANDRIN G., MÜLLER-HERMELINK H.K., VARDIMAN J., LISTER T.A., BLOOMFIELD C.D. — World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue: Report of the Clinical Advisory Committee Meeting — Airlie House, Virginia, November 1997.J. Clin. Oncol., 1999,17, 3835–3849.
CAMPO E., RAFFELD M., JAFFE E.S. — Mantle-cell lymphoma.Semin. Hematol., 1999,36, 115–127.
FRANSSILA K.O., JASER N., SIVULA A. — Gastrointestinal non-Hodgkin's lymphoma. A population-based clinicopathological study of 111 adults with a follow-up of 10–15 years.APMIS, 1993,101, 631–641.
HARRIS N.L., JAFFE E.S., STEIN H., BANKS P., CHAN J.K.C., CLEARY M.L., DELSOL G., DE WOLF-PEETERS C., FALINI B., GATTER K.C., GROGAN T.M., ISAACSON P.G., KNOWLES D.M., MASON D.Y., MÜLLER-HERMELINK H.K., PILERI S.A., PIRIS M.A., RALFKIAER E., WARNKE R.A. — Lymphoma Classification Proposal: Clarification.Blood, 1995,85, 857–860.
FRIZZERA G., WU D., INGHIRAMI G. — The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update.Am. J. Clin. Pathol., 1999,111 (Suppl. 1), S13-S39.
WATSON P., WOOD K.M., LODGE A., McINTOCH G.G., MILTON I., PIGGOTT N.H., PROCTOR S.J., TAYLOR P.R., SMITH S., JACK F., BELL H., STEWARD M., ANDERSON J.J., HORNE C.H.W., ANGUS B. — Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma.Histopathology, 2000,36, 145–150.
ZUKERBERG L.R., MEDEIROS J.L., FERRY J.A., HARRIS N.L. — Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.Am. J. Clin. Pathol., 1993,100, 373–385.
FRAGA M., LLORET E., SANCHEZ-VERDE L., ORRADRE J.L., CAMPO E., BOSCH F., PIRIS M.A. — Mucosal mantle cell (centrocytic) lymphomas.Histopathology, 1995,26, 413–422.
ISAACSON P.G., MacLENNAN K.A., SUBBRUSWAMY S.G. — Multiple lymphomatous polyposis of the gastrointestinal tract.Histopathology, 1984,8, 641–656.
LAVERGNE A., BROULAND J.P., LAUNAY E., NEMETH J., RUSKONE-FOURMESTRAUX A., GALIAN A. — Multiple lymphomatous polyposis of the gastrointestinal tract. An extensive histopathologic and immunohistochemical study of 12 cases.Cancer, 1994,74, 3042–3050.
RUSKONÉ-FOURMESTRAUX A., DELMER A., LAVERGNE A., MOLINA T., BROUSSE N., AUDOUIN J., RAMBAUD J.C., Groupe d'Etude des Lymphomas Digestifs. — Multiple lymphomatous polyposis of the gastrointestinal tract: Clinicopathologic study of 31 cases.Gastroenterology, 1997,112, 7–16.
CORNES J.S. — Multiple lymphomatous polyposis of the gastrointestinal tract.Cancer, 1961,14, 249–257.
HIRAKAWA K., FUCHIGAMI T., NAKAMURA S., DAIMARU Y., OHSHIMA K., SAKAI Y., ICHIMARU T. — Primary gastrointestinal T-cell lymphoma resembling multiple lymphomatous polyposis.Gastroenterology, 1996,111, 778–782.
MOYNIHAN M.J., BAST M.A., CHAN W.C., DELABIE J., WICKERT R.S., WU G., WEISENBURGER D.D. — Lymphomatous polyposis. A neoplasm of either follicular mantle or germinal center cell origin.Am. J. Surg. Pathol., 1996,20, 442–452.
O'BRIAIN D.S., KENNEDY M.J., DALY P.A., O'BRIEN A.A.J., TANNER W.A., ROGER P., LAWLOR E. — Multiple lymphomatous polyposis of the gastrointestinal tract. A clinicopathologically distinctive form of non-Hogkin's lymphoma of B-cell centrocytic type.Am. J. Surg. Pathol., 1989,13, 691–699.
KUMAR S., KRENACS L., OTSUKI T., KUMAR D., HARRIS C.A., WELLMANN A., JAFFE E.S., RAFFELD M. — Bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis.Am. J. Clin. Pathol., 1996,105, 737–743.
CHEN C.C., RAIKOW R.B., SONMEZ-ALPAN E., SWERDLOW S.H. — Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.Appl. Immunohistochem. Mol. Morphol., 2000,8, 1–11.
RAFFELD M., JAFFE E.S. — Bcl-1, t(11;14), and mantle cell-derived lymphomas.Blood, 1991,78, 259–263.
ROSENBERG C.L., WONG E., PETTY E.M., BALE A.E., TSUJIMOTO Y., HARRIS N.L., ARNOLD A. — PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.Proc. Natl. Acad. Sci. USA, 1991,88, 9636–9642.
MOTOKURA T., BLOOM T., KIM H.G., JUPPNER H., RUDERMAN J.V., KRONENBERG H.M., ARNOLD A. — A novel cyclin encoded by BCL1-linked candidate oncogene.Nature, 1991,350, 512–515.
KUSE R., LUEB H. — Gastrointestinal involvement in patients with chronic lymphocytic leukaemia.Leukemia, 1997,11 (Suppl 2), S50-S51.
GUPTA D., LIM M.S., MEDEIROS J., ELENITOBA-JOHNSON K.S.J. — Small lymphocytic lymphoma with perifollicular, marginal zone, or interfollicular distribution.Mod. Pathol., 2000,13, 1161–1166.
ELLISON D.J., NATHWANI B.N., CHO S.Y., MARTIN S.E. — Interfollicular small lymphocytic lymphoma: the diagnostic significance of pseudofollicles.Hum. Pathol., 1989,20, 1108–1118.
REYNES M., AUBERT J.P., COHEN J.H.M., AUDOUIN J., TRICOTTET V., DIEBOLD J., KAZATCHKINE M.D. — Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.J. Immunol., 1985,135, 2687–2694.
ISAACSON P.G. — Malignant lymphomas with a follicular growth pattern.Histopathology, 1996,28, 487–495.
LeBRUN D.P., KAMEL O.W., CLEARY M.L., DORFMAN R.F., WARNKE R.A. — Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression.Am. J. Pathol., 1992,140, 1327–1335.
YOSHINO T., MIYAKE K., ICHIMURA K., MANNAMI T., OHARA N., HAMAZAKI S., AKAGI T. — Increased incidence of follicular lymphoma in the duodenum.Am. J. Surg. Pathol., 2000,24, 688–693.
HARRIS N.L., FERRY J.A. — Follicular lymphoma.In: Neoplastic hematopathology (2nd Ed), Knowles DM (Ed), Lippincott Williams & Wilkins, Philadelphia, 2001, p. 823–853.
HARRIS N.L. — Principles of the revised European-American lymphoma classification (from the International Lymphoma Study Group).Ann. Oncol., 1997,8(Suppl. 2), S11-S16.
CHAN J.K.C. — Gastrointestinal lymphomas: An overview with emphasis on new findings and diagnostic problems.Seminars in Diagnostic Pathology, 1996,13, 260–296.
BANKS P.M., CHAN J., CLEARY M.L., DELSOL G., DE WOLF-PEETERS C., GATTER K., GROGAN T.M., HARRIS N.L., ISAACSON P.G., JAFFE E.S., MASON D., PILERI S., RALFKIAER E., STEIN H., WARNKE E.A. — Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data.Am. J. Surg. Pathol., 1992,16, 637–640.
ISAACSON P.G., WOTHERSPOON A.C., DISS T., PAN L. — Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue.Am. J. Surg. Pathol., 1991,15, 819–828.
BANKS P.M. — Microscopic mimicry of lymphomas: Diagnostic pitfalls.Mod. Pathol., 1999,12, 116–124.
ANAISSIE E., GEHA S., ALLAM C., JABBOUR J., KHALYL M., SALEM P. — Burkitt's lymphoma in the Middle East: a study of 34 cases.Cancer, 1985,56, 2539–2543.
LADJADJ Y., PHILIP T., LENOIR G.M., TAZEROUT F.Z., BENDISARI K., BOUKHELOUA R., BIRON P., BRUNAT-MENTIGNY M., ABOULOLA M. — Abdominal Burkitt-type lymphomas in Algeria.Br. J. Cancer, 1984,49, 503–512.
WRIGHT D.H. — Gross distribution and haematology.In: Burkitt D, Wright D (Eds): Burkitt lymphoma. London: E & S Livingstone, 1970, p. 64–81.
MAGRATH I., JAFFE E.S., BHATIA K. — Burkitt's lymphoma.In: Neoplastic hematopathology (2nd Ed), Knowles DM (Ed), Lippincott Williams & Wilkins, Philadelphia, 2001, p. 953–986.
ISAACSON P.G. — Gastrointestinal lymphomas and lymphoid hyperplasias. Neoplastic hematopathology (2nd Ed), Knowles DM (Ed), Lippincott Williams & Wilkins, Philadelphia, 2001, p. 1235–1261.
HECHT J.L., ASTER J.C. — Molecular biology of Burkitt's lymphoma.J. Clin. Oncol., 2000,18, 3707–3721.
ZUR HAUSEN H., SCHULTE-HOLTHAUSEN H., KLEIN G., HENLE W., HENLE G., CLIFFORD P., SANTESSON L. — EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.Nature, 1970,228, 1056–1058.
ANAGNOSTOPOULOS I., DALLENBACH F., STEIN H. — Diffuse large cell lymphoma.In: Neoplastic hematopathology (2nd Ed), Knowles DM (Ed), Lippincott WIlliams & Wilkins, Philadelphia, 2001, p. 855–913.
GROGAN T., WARNKE R., KAPLAN H. — A comparative study of Burkitt's and non-Burkitt's «undifferentiated» malignant lymphoma: immunohistologic, cytochemical, ultrastructural, cytologic, histopathologic, clinical and cell culture features.Cancer, 1982,49, 1817–1828.
CHAN J.K.C., ISAACSON P.G. — Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach.Am. J. Pathol., 1990,136, 1153–1164.
WOTHERSPOON A.C., FINN T., ISAACSON P.G. — Numerical abnormalities of chromosomes 3 and 7 in lymphomas of mucosa-associated lymphoid tissue and the splenic marginal zone.Lab. Invest., 1994,70, A124.
DRIESSEN A., TIERENS A., ECTORS N., PITTALUGA S., GEBOES K., DELABIE J., DE WOLFPEETERS C. — Primary gastric diffuse large B-cell lymphoma: somatic mutations in the rearranged IgH variable genes indicates antigen selection.Leukemia, 1999,13, 1085–1092.
OTT G., KATZENBERGER T., GREINER, A., KALLA J., ROSENWALD A., HEINRICH U., OTT M.M., MÜLLER-HERMELINK H.K. — The t(11;18)(q21; q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant Non-Hodgkin's lymphomas of the Mucosa-Associated Lymphoid Tissue (MALT-) type.Cancer Res., 1997,57, 3944–3948.
MAES B., BAENS M., MARYNEN P., DE WOLF-PEETERS C. — The product of the t(11;18), an API22-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type.Ann. Oncol., 2000,11, 521–526.
CHOTT A., VESELY M., SIMONITSCH I., MOSBERGER I., HANAK H. — Classification of intestinal T-cell neoplasms and their differential diagnosis.Am. J. Clin. Pathol., 1999,111 (Suppl. 1), S68-S74.
ASHTON-KEY M., DISS T.C., PAN L., DU M.Q., ISAACSON P.G. — Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma.Am. J. Pathol., 1997,151, 493–498.
DOMIZIO P., OWEN R.A., SHEPHERD N.A., TALBOT J.C., NORTON A.J. — Primary lymphoma of the small intestine. A clinicopathological study of 119 cases.Am. J. Surg. Pathol., 1993,17, 429–442.
HASTRUP N., HAMILTON-DUTOIT S., RALFKIAER E., PALLESEN G. — Peripheral T-cell lymphomas: an evaluation of reproducibility of the updated Kiel classification.Histopathology, 1991,18, 99–105.
CHOTT A., DRAGOSICS B., RADASZKIEWICZ T. — Peripheral T-cell lymphomas of the intestine.Am. J. Pathol., 1992,141, 1361–1371.
DE BRUIN P.C., CONNOLLY C.E., OUDEJANS J.J., KUMMER J.A., JANSEN W., McCARTHY C.F., MEIJER C.J. — Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype.Histopathology, 1997,31, 313–317.
WRIGHT D.H. — Enteropathy-associated T cell lymphoma.Cancer Surv., 1997,30, 249–261.
CHOTT A., HAEDICKE W., MOSBERGER I., FÖDINGER M., WINKLER K., MANHALTER C., MÜLLER-HERMELINK H.K. — Most CD56+ intestinal lymphomas are CD8+CD5- T-cell lymphomas of monomorphic small to medium size histology.Am. J. Pathol., 1998,153, 1483–1490.
SPENCER J., CERF-BENSUSSAN N., JARRY A., BROUSSE N., GUY-GRAND D., KRAJEWSKI A.S., ISAACSON P.G. — Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes.Am. J. Pathol., 1988,132, 1–5.
DE WOLF-PEETERS C., ACHTEN R. — γδ T-cell lymphomas: a homogeneous entity?Histopathology, 2000,36, 294–305.
ARNULF B., COPIE-BERGMAN C., DELFAU-LARUE M.H., LAVERGNE-SLOVE A., BOSQ J., WECHSLER J., WASSEF M., MATUCHANSKY C., EPARDEAU B., STERN M., BAGOT M., REYES F., GAULARD P. — Nonhepatosplenic γδ T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal and skin localization.Blood, 1998,91, 1723–1731.
HALSTENSEN T.S., SCOTT, H., BRANDTZAEG P. — Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in celiac disease.Scand. J. Immunol., 1989,30, 665–672.
WOOD N.L., COLTMAN C.A. — Localized primary extranodal Hodgkin's disease.Ann. Intern. Med., 1973,78, 113–118.
DEVANEY K., JAFFE E.S. — The surgical pathology of gastrointestinal Hodgkin's disease.Am. J. Clin. Pathol., 1991,95, 794–801.
SHEPHERD N.A., HALL P.A., WILLIAMS G.T., CODLING B.W., JONES E.L., LEVISON D.A., MORSON B.C. — Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease.Histopathology, 1989,15, 325–337.
BURKE J.S. — Hodgkin's disease: Histopathology and differential diagnosis.In: Neoplastic hematopathology (2nd Ed), Knowles DM (Ed), Lippincott Williams & Wilkins, Philadelphia, p. 623–690.
PALLI D., TRALLORI G., BAGNOLI S., SAIEVA C., TARANTINO O., CEROTI M., D'ALBASIO G., PACINI F., AMOROSI A., MASALA G. — Hodgkin's disease risk is increased in patients with ulcerative colitis.Gastroenterology, 2000,119, 647–653.
BERNSTEIN C.N., BLANCHARD J.F., KLIEWER E., WAJDA A. — Cancer risk in patients with inflammatory bowel disease. A population-based study.Cancer, 2001,91, 852–862.
FARRELL R.J., ANG Y., KILEEN P., O'BRIAIN D.S., KELLEHER D., KEELING P.W.N., WEIR D.G. — Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.Gut, 2000,47, 514–519.
KUMAR S., FEND F., QUINTANILLA-MARTINEZ L., KINGMAN D.W., SORBARA L., RAFFELD M., BANKS P.M., JAFFE E.S. — Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease. Association with inflammatory bowel disease and immunosuppression.Am. J. Surg. Pathol., 2000,24, 66–73.
LI S., BOROWITZ M.J. — Primary Epstein-Barr virus-associated Hodgkin disease of the ileum complicating Crohn disease.Arch. Pathol. Lab. Med., 2001,125, 424–427.
GENTA R.M., HAMMER H.W., GRAHAM D.Y. — Gastric lymphoid follicles inHelicobacter pylori infection: frequency, distribution and response to triple therapy.Hum. Pathol., 1993,24, 577–583.
PARSONNET J., HANSEN S., RODRIGUEZ L., GELB A.B., WARNKE R.A., JELLUM E., ORENTREICH N., VOGELMANN J.H., FRIEDMAN G.D. —Helicobacter pylori infection and gastric lymphoma.N. Engl. J. Med., 1994,330, 1267–1271.
GREINER A., MARX A., HEESEMANN J., LEEBMAN J., SCHMAU\ER B., MÜLLER-HERMELINK H.K. — Idiotype identity in a MALT-type lymphoma and B cells inHelicobacter pylori associated chronic gastritis.Lab. Invest., 1994,70, 572–578.
HUSSELL T., ISAACSON P.G., CRABTREE J.E., SPENCER J. — The response of cells from low-grade B-cell gastric lymphomas of Mucosa-Associated Lymphoid Tissue toHelicobacter pylori.Lancet, 1993,342, 571–574.
HUSSELL T., ISAACSON P.G., CRABTREE J.E., SPENCER J. —Helicobacter pylori-specific tumour-infiltrating T-cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of Mucosa-Associated Lymphoid Tissue.J. Pathol., 1996,178, 122–127.
D'ELIOS M.M., AMEDEI A., MANGHETTI M., COSTA F., BALDARI C.T., QUAZI A.S., TELFORD J.L., ROMAGNANI S., DEL PRETE G. — Impaired T-cell regulation of B-cell growth inHelicobacter pylori-related gastric low-grade MALT lymphoma.Gastroenterology, 1999,117, 1105–1112.
STOLTE M., MORGNER A., MEINING A., THIEDE C.H., WÜNDISCH T.H., BAYERDÖRFFER E., NEUBAUER A. — Early and long-term results ofHelicobacter pylori cure of MALT-lymphoma — what are the pitfalls?In: Hunt R.H., Tytgat G.N.J. (Eds):Helicobacter pylori. Basic mechanisms to clinical cure 1998. Dordrecht Kluwer Academic Publishers, 1998, p. 373–380.
RUSKONÉ-FOURMESTRAUX A., LAVERGNE A., AEGERTER P.H., MEGRAUD F., PALAZZO L., DE MASCAREL A., MOLINA T., RAMBAUD J.C.L., The Groupe d'Etude des Lymphomes Digestifs (GELD). — Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.Gut, 2001,48, 297–303.
ISAACSON P.G. — Gastric MALT lymphoma: From concept to cure.Ann. Oncol., 1999,10, 637–645.
LIU H., RUSKONÉ-FOURMESTRAUX A., LAVERGNE-SLOVE A., YE H., MOLINA T., BOUHNIK Y., HAMOUDI R.A., DISS T.C., DOGAN A., MEGRAUD F., RAMBAUD J.C., DU M.Q., ISAACSON P.G. — Resistance of t(11;18) positive gastric mucosa associated lymphoid tissue lymphoma toHelicobacter pylori eradication therapy.Lancet, 2001,357, 39–48.
LEWIS J.D., DEREN J.J., LICHTENSTEIN G.R. — Cancer risk in patients with inflammatory bowel disease.Gastroenterol. Clin. North. Am., 1999,28, 459–477.
LOFTUS E.V., TREMAINE W.J., HABERMANN T.M., HARMSEN S., ZINSMEISTER A.R., SANDBORN W.J. — Risk of lymphoma in inflammatory bowel disease.Am. J. Gastroenterol., 2000,95, 2308–2312.
GREENSTEIN A.J., MULLIN G.E., STRAUCHEN J.A., HEIMANN T., JANOWITZ H.D., AUFSES A.H. JR., SACHAR D.B. — Lymphoma in inflammatory bowel disease.Cancer, 1992,69, 1119–1123.
BEBB J.R., LOGAN P.H. — Review article: Does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?Aliment. Pharmacol. Ther., 2001,15, 1843–1849.
RUTGEERTS P., D'HAENS G., TARGAN S., VASILAUSKAS E., HANAUER S.B., PRESENT D.H., MAYER L., VAN HOGEZAND R.A., BRAAKMAN T., DEWOODY K.L., SCHAIBLE T.F., VAN DEVENTER S.J. — Efficacy and safety of retreatment with anti-Tumour Necrosis Factor antibody (Infliximab) to maintain remission in Crohn's disease.Gastroenterology, 1999,117, 761–769.
BICKSTON S.J., LICHTENSTEIN G.R., ARSENAU K.O., COHEN R.B., COMINELLI F. — The relationship between infliximab treatment and lymphoma in Crohn's disease.Gastroenterology, 1999,117, 1433–1437.
KNOWLES D.M. — Immunodeficiency-associated lymphoproliferative disorders.Mod. Pathol., 1999,12, 200–217.
FRIEDMAN H.B., SILVER G.M., BROWN C.H. — Lymphoma of the colon simulating ulcerative colitis: report of four cases.Am. J. Dig. Dis., 1968,13, 910–917.
CANIONI D., JABADO N., MacINTYRE E., PATEY N., EMILE J.F., BROUSSE N. — Lymphoproliferative disorders in children with primary immunodefiencies: immunological status may be more predictive of the outcome than other criteria.Histopathology, 2001,38, 146–159.
SERRIANO D., SALAMINA G., FRANCESCHI S., DUBOIS D., LA VECCHIA C., BRUNET J.B., ANCELLEPARK R.A. — The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European region.Br. J. Cancer, 1992,66, 912–916.
GISSELBRECHT C., OKSENJENDLER E., TIRELLI U., GABARRE J., GASTALDI R., FARCET J.P., THYSS A., COIFFIER B., RAPHAEL M., LEPAGE E. — Non-Hodgkin's lymphoma associated with human immunodefiency virus: Treatment with the LNH 84 regimen in a selected group of patients.Leukemia, 1992 (suppl. 3), 10S-11S.
STRAUS D.J. — HIV-associated lymphomas.Curr. Opin. Oncol., 1997,9, 450–454.
IOACHIM H.L., DORSETT B., CRONIN W., MAYA M., WAHL S. — Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic and viral characteristics of 111 cases.Hum. Pathol., 1991,22, 659–673.
DeMARIO M.D., LIEBOWITZ D.N. — Lymphomas in the immunocompromised patient.Semin. Oncol., 1998,25, 492–502.
PENN I. — Cancers following cyclosporine therapy.Transplantation, 1987,43, 32–35.
KAMEL O.W. — Iatrogenic lymphoproliferative disorders in non-transplantation settings.Semin. Diagn. Pathol., 1997,14, 27–34.
MASOOD R., ZHANG Y., BOND M.W., SCADDEN D.T., MOUDGIL T., LAW R.E., KAPLAN M.H., JUNG B., ESPINA B.M., LUNARDI-ISKANDAR Y.et al. — Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma.Blood, 1995,85, 3423–3430.
IOACHIM H.L., ANTONESCU C., GIANCOTTI F., DORSETT B., WEINSTEIN M.A. — EBV-associated anorectal lymphomas in patients with acquired immune deficiency syndrome.Am. J. Surg. Pathol., 1997,21, 997–1006.
SWINSON C.M., COLES E.C., SLAAVIN G., BOOTH C.C. — Coeliac disease and malignancy.Lancet, 1983,i, 111–115.
HOLMES G.K.T., STOKES P.L., SORAHAN T.M., PRIOR P., WATERHOUSE J.A.M., COOKE W.T. — Coeliac disease, gluten free diet and malignancy.Gut, 1976,17, 612–619.
SELBY W.S., GALLAGHER N.D. — Malignancy in a 19 year experience of adult celiac disease.Dig. Dis. Sci., 1979,24, 684–687.
ISAACSON P., WRIGHT D.H. — Malignant histiocytosis of the intestine. Its relationship to malabsorption and ulcerative jejunitis.Hum. Pathol., 1978,9, 661–677.
JENNINGS J.S.R., HOWDLE P.D. — Celiac disease.Curr. Opin. Gastroenterol., 2001,17, 118–126.
JEWELL D.P. — Ulcerative enteritis.Br. Med. J., 1983,287, 1740–1741.
PATEY-MARIAUD DE SERRE N., CELLIER C., JABRI B., DELABESSE E., VERKARRE V., ROCHE B., LAVERGNE A., BRIERE J., MAUVIEUX L., LEBORGNE M., BARBIER J.P., MODIGLIANI R., MATUCHANSKY C., MacINTYRE E., CERF-BENSUSSAN N., BROUSSE N. — Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method.Histopathology, 2000,37, 70–77.
BAGDI E., DISS T.C., MUNSON P., ISAACSON P.G. — Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population.Blood, 1999,94, 260–264.
CARBONNEL F., GROLLET-BIOUL L., BROUET J.C., TEILHAC M.F., COSNES J., ANGONIN R., DESCHASEAUX M., CHÂTELET F.P., GENDRE J.P., SIGAUX F. — Are complicated forms of celiac disease cryptic T-cell lymphomas?Blood, 1998,92, 3879–3886.
CELLIER C., DELABESSE E., HELMER, C., PATEY N., MATUCHANSKY C., JABRI B., MacINTYRE E., CERFBENSUSSAN N., BROUSSE N. — French coeliac disease study group. — Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma.Lancet, 2000,356, 203–208.
DAUM S., HUMMEL M., WEISS D., PETERS M., WIEDENMANN B., SCHÄPER F., STEIN H., RIECKEN E.O., FOSS H.D. — Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma.Digestion, 2000,62, 60–65.
JAFFE E.S., HARRIS N.L., STEIN H., VARDIMAN J.W. — World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, 2001, 351 pp.
GEBOES K. — Small intestinal tumours.In: Tytgat G.N.J. (Ed.): Gastrointestinal and liver tumours (In preparation).
Author information
Authors and Affiliations
About this article
Cite this article
Driessen, A., Ectors, N. Lymphomes du tractus gastro-intestinal: types rares. Acta Endosc 33, 327–345 (2003). https://doi.org/10.1007/BF03015747
Issue Date:
DOI: https://doi.org/10.1007/BF03015747
Mots-clés
- Helicobacter pylori
- immunodéficience
- lymphome de Burkitt
- lymphomes de la zone marginale
- lymphome de type diffus à grandes cellules B
- lymphome des cellules du manteau
- lymphome folliculaire
- lymphomes T associés à une entéropathie
- maladie cœliaque
- MICI